SuperValu Inc. Loperamide Hydrochloride Oral Suspension Drug Facts

Manufacturer
Supervalu Inc
Effective date
2018-01-23
Label type
HUMAN OTC DRUG LABEL
Version
5
Source
legacy-cache
Hydrated at
2026-08-02 01:04:28

Label at a glance#

ProductEqualine loperamide hydrochloride
Active ingredientLOPERAMIDE HYDROCHLORIDE
Label structure9 sections

Dosage and administration

• drink plenty of clear fluids to help prevent dehydration caused by diarrhea • find right dose on chart. If possible, use weight to dose; otherwise use age. • shake well before using • only use attached measuring cup to dose product adults and children 12 years and over 30 mL (6 tsp) after the first loose stool; 15 mL (3 tsp) after each subsequent loose stool; but no more than 60 mL (12 tsp) in 24 hours children ...

Storage and handling

• each 30 mL (6 tsp) contains: sodium 15 mg • store between 20-25°C (68-77°F) • see side panel for lot number and expiration date

Label contents#

Full prescribing information#

Active ingredient (in each 7.5 mL)

OTC - ACTIVE INGREDIENT SECTION

Loperamide HCl 1 mg

Purpose

OTC - PURPOSE SECTION

Anti-diarrheal

Use

INDICATIONS & USAGE SECTION

controls symptoms of diarrhea, including Travelers’ Diarrhea

Warnings

WARNINGS SECTION

Allergy alert: Do not use if you have ever had a rash or other allergic reaction to loperamide HCl

Do not use

OTC - DO NOT USE SECTION

if you have bloody or black stool

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • fever
  • mucus in the stool
  • a history of liver disease

Ask a doctor or pharmacist before use if you are

OTC - ASK DOCTOR/PHARMACIST SECTION

taking antibiotics

When using this product

OTC - WHEN USING SECTION

  • tiredness, drowsiness or dizziness may occur. Be careful when driving or operating machinery.

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • symptoms get worse
  • diarrhea lasts for more than 2 days
  • you get abdominal swelling or bulging.

These may be signs of a serious condition.

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Directions

DOSAGE & ADMINISTRATION SECTION

  • drink plenty of clear fluids to help prevent dehydration caused by diarrhea
  • find right dose on chart. If possible, use weight to dose; otherwise use age.
  • shake well before using
  • only use attached measuring cup to dose product

adults and children 12 years and over

30 mL (6 tsp) after the first loose stool; 15 mL (3 tsp) after each subsequent loose stool; but no more than 60 mL (12 tsp) in 24 hours

children 9-11 years (60-95 lbs)

15 mL (3 tsp) after the first loose stool; 7.5 mL (1 1/2 tsp) after each subsequent loose stool; but no more than 45 mL (9 tsp) in 24 hours

children 6-8 years (48-59 lbs)

15 mL (3 tsp) after the first loose stool; 7.5 mL (1 1/2 tsp) after each subsequent loose stool; but no more than 30 mL (6 tsp) in 24 hours

children under 6 years (up to 47 lbs)

ask a doctor

Other information

STORAGE AND HANDLING SECTION

  • each 30 mL (6 tsp) contains: sodium 15 mg
  • store between 20-25°C (68-77°F)
  • see side panel for lot number and expiration date

Inactive ingredients

INACTIVE INGREDIENT SECTION

anhydrous citric acid, carboxymethylcellulose sodium, D&C yellow no. 10, FD&C blue no. 1, glycerin, microcrystalline cellulose, natural and artificial mint flavor, propylene glycol, purified water, simethicone, sodium benzoate, sucralose, titanium dioxide, xanthan gum

Questions or comments?

OTC - QUESTIONS SECTION

1-877-932-7948

Package/Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

compare to Imodium® A-D active ingredient

loperamide hydrochloride oral suspension

anti-diarrheal

controls the symptoms of diarrhea

mint flavor

1 mg loperamide hydrochloride per 7.5 mL

4 FL OZ (120mL)

Equaline Loperamide Hydrochloride Oral Suspension Image 1
Equaline Loperamide Hydrochloride Oral Suspension Image 1
Equaline Loperamide Hydrochloride Oral Suspension Image 2
Equaline Loperamide Hydrochloride Oral Suspension Image 2

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
41163-645-26ML - Milliliter41163-6450ff26082-c8ca-4f96-82c0-f5faf2298cc512013-02-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
LOPERAMIDE HYDROCHLORIDEACTIVE INGREDIENT77TI35393C4
LOPERAMIDEACTIVE MOIETY6X9OC3H4II4
ANHYDROUS CITRIC ACIDINACTIVE INGREDIENTXF417D3PSL4
CARBOXYMETHYLCELLULOSE SODIUMINACTIVE INGREDIENTK679OBS3114
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61U4
D&C YELLOW NO. 10INACTIVE INGREDIENT35SW5USQ3G4
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBD4
GLYCERININACTIVE INGREDIENTPDC6A3C0OX4
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V34
SODIUM BENZOATEINACTIVE INGREDIENTOJ245FE5EU4
SUCRALOSEINACTIVE INGREDIENT96K6UQ3ZD44
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JP4
WATERINACTIVE INGREDIENT059QF0KO0R4
XANTHAN GUMINACTIVE INGREDIENTTTV12P4NEE4

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 16 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
41163-64541163-645-26

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 13 matching rows.

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 9 · 483 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
CARBOXYMETHYLCELLULOSE SODIUMCARBOXYMETHYLCELLULOSE SODIUMK679OBS311TABLET / ORAL280 mgExact identifier — unii candidate
44 equally ranked IID candidates
FD&C BLUE NO. 1FD&C BLUE NO. 1H3R47K3TBDTABLET, COATED / ORAL0.52 mgExact identifier — unii candidate
37 equally ranked IID candidates
D&C YELLOW NO. 10D&C YELLOW NO. 1035SW5USQ3GSYRUP / ORAL4 mgExact identifier — unii candidate
31 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCAPSULE, DELAYED RELEASE / ORAL55 mgExact identifier — unii candidate
40 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SYSTEM / TOPICAL4200 mgExact identifier — unii candidate
81 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXOINTMENT / TOPICALNAExact identifier — unii candidate
75 equally ranked IID candidates
SUCRALOSESUCRALOSE96K6UQ3ZD4SPRAY, METERED / NASAL2 mgExact identifier — unii candidate
22 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPPOWDER / RESPIRATORY (INHALATION)2 mgExact identifier — unii candidate
40 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3AEROSOL, FOAM / RECTAL1214 mgExact identifier — unii candidate
81 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLTABLET / ORAL197 mgExact identifier — unii candidate
61 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3AEROSOL / TOPICAL19.2 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLCAPSULE / ORAL131 mgExact identifier — unii candidate
61 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUMCARBOXYMETHYLCELLULOSE SODIUMK679OBS311POWDER, FOR SOLUTION / ORAL161 mgExact identifier — unii candidate
44 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION, CONCENTRATE / ORAL2590 mgExact identifier — unii candidate
81 equally ranked IID candidates
FD&C BLUE NO. 1FD&C BLUE NO. 1H3R47K3TBDCAPSULE / ORAL26.3 mgExact identifier — unii candidate
37 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXCREAM / TOPICAL1720 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXTABLET, FILM COATED / ORAL1.55 mgExact identifier — unii candidate
75 equally ranked IID candidates
FD&C BLUE NO. 1FD&C BLUE NO. 1H3R47K3TBDPASTE, DENTIFRICE / DENTALNAExact identifier — unii candidate
37 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCAPSULE, LIQUID FILLED / ORAL12 mgExact identifier — unii candidate
40 equally ranked IID candidates
D&C YELLOW NO. 10D&C YELLOW NO. 1035SW5USQ3GSUSPENSION, EXTENDED RELEASE / ORAL1 mgExact identifier — unii candidate
31 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UGRANULE, DELAYED RELEASE / ORAL789.6 mgExact identifier — unii candidate
28 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / ORAL22602 mgExact identifier — unii candidate
81 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET, FILM COATED, EXTENDED RELEASE / ORAL11 mgExact identifier — unii candidate
40 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLSUSPENSION, EXTENDED RELEASE / ORAL62 mgExact identifier — unii candidate
61 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUMCARBOXYMETHYLCELLULOSE SODIUMK679OBS311INJECTION, SUSPENSION / INTRALESIONAL15 mgExact identifier — unii candidate
44 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEETABLET, ORALLY DISINTEGRATING / ORAL0.15 mgExact identifier — unii candidate
29 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPGUM, CHEWING / BUCCAL182 mgExact identifier — unii candidate
40 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLINJECTION / INTRAVENOUS1152 mgExact identifier — unii candidate
61 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUMCARBOXYMETHYLCELLULOSE SODIUMK679OBS311SOLUTION / ORAL3480 mgExact identifier — unii candidate
44 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET / ORAL232 mgExact identifier — unii candidate
40 equally ranked IID candidates
SUCRALOSESUCRALOSE96K6UQ3ZD4GRANULE / ORAL5.4 mgExact identifier — unii candidate
22 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3AEROSOL, METERED / RECTALNAExact identifier — unii candidate
81 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEESOLUTION / ORAL84 mgExact identifier — unii candidate
29 equally ranked IID candidates
SODIUM BENZOATESODIUM BENZOATEOJ245FE5EUSUSPENSION, EXTENDED RELEASE / ORAL24 mgExact identifier — unii candidate
35 equally ranked IID candidates
D&C YELLOW NO. 10D&C YELLOW NO. 1035SW5USQ3GTABLET, DELAYED RELEASE / ORAL1.9 mgExact identifier — unii candidate
31 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / ORAL32400 mgExact identifier — unii candidate
75 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, FILM COATED, EXTENDED RELEASE / ORAL19 mgExact identifier — unii candidate
81 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLSOLUTION/ DROPS / AURICULAR (OTIC)1 mgExact identifier — unii candidate
61 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEETABLET / ORAL56 mgExact identifier — unii candidate
29 equally ranked IID candidates
D&C YELLOW NO. 10D&C YELLOW NO. 1035SW5USQ3GGEL / TOPICALNAExact identifier — unii candidate
31 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3LIQUID / RESPIRATORY (INHALATION)10 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEESOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC0.6 %w/wExact identifier — unii candidate
29 equally ranked IID candidates
SODIUM BENZOATESODIUM BENZOATEOJ245FE5EUSUSPENSION/ DROPS / ORAL23 mgExact identifier — unii candidate
35 equally ranked IID candidates
FD&C BLUE NO. 1FD&C BLUE NO. 1H3R47K3TBDPOWDER, FOR SUSPENSION / ORAL1 mg/5mlExact identifier — unii candidate
37 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLSOLUTION / OPHTHALMIC0.09 %w/vExact identifier — unii candidate
61 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEECREAM / TOPICAL46 mgExact identifier — unii candidate
29 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEESUSPENSION / ORAL360 mgExact identifier — unii candidate
29 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPFILM, SOLUBLE / ORAL2 mgExact identifier — unii candidate
40 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UTROCHE / ORAL300 mgExact identifier — unii candidate
28 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUMCARBOXYMETHYLCELLULOSE SODIUMK679OBS311INJECTION / INTRA-ARTICULAR25 mgExact identifier — unii candidate
44 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLTABLET, CHEWABLE, EXTENDED RELEASE / ORAL12 mgExact identifier — unii candidate
61 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3OINTMENT / TOPICAL5148 mgExact identifier — unii candidate
81 equally ranked IID candidates
FD&C BLUE NO. 1FD&C BLUE NO. 1H3R47K3TBDSOLUTION / TOPICAL0.01 %w/wExact identifier — unii candidate
37 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXINJECTION, SOLUTION / INTRAMUSCULAR15 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION/ DROPS / AURICULAR (OTIC)25 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXDROPS / ORAL300 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPSYSTEM / TOPICAL420 mgExact identifier — unii candidate
40 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCAPSULE / ORAL72 mgExact identifier — unii candidate
40 equally ranked IID candidates
D&C YELLOW NO. 10D&C YELLOW NO. 1035SW5USQ3GCAPSULE, COATED PELLETS / ORAL0.01 mgExact identifier — unii candidate
31 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLSUSPENSION/ DROPS / ORAL15 mgExact identifier — unii candidate
61 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A091292-001LOPERAMIDE HYDROCHLORIDELOPERAMIDE HYDROCHLORIDE1MG/7.5MLSOLUTION / ORAL2011-05-20

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSOLUTION / ORAL2011-05-2084e616aacf4f…
2026-08-18 06:07:402026-07A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSOLUTION / ORAL2011-05-20caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSOLUTION / ORAL2011-05-20011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSOLUTION / ORAL2011-05-2031067a03dcf5…
2025-08-23 18:47 UTC2025-08A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-206a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-20fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-20b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-2003ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-202680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-205bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-20d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-20d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-2079d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-20301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-201e350fbaab3a…
2024-05-31 18:47 UTC2024-05A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-208072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-205c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-205d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-204b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-2074a2ff9319b5…
2022-03-09 01:35 UTC2022-03A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-20bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-20782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-2087673890dc5c…
2021-03-12 10:30 UTC2021-03A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-205aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-208869cabd3fbd…
2020-11-12 02:37 UTC2020-11A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-20c0c555d07b60…
2019-12-14 00:12 UTC2019-12A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-203f01610625f2…
2019-09-15 20:21 UTC2019-09A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-20b00525d2431f…
2019-07-19 19:46 UTC2019-07A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-20ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-206a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-201c564ffb4f44…
2023-12-20 04:57 UTC2023-12A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-20ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-20a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-209b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-20a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-203f0d92c62455…
2023-05-13 08:27 UTC2023-05A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-20053a50430f4f…
2023-01-26 05:58 UTC2023-01A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-203bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-203a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A091292-001LOPERAMIDE HYDROCHLORIDE1MG/7.5MLSUSPENSION / ORAL2011-05-20f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
5a407da0-b3f2-4f39-96fb-cbad1c48dffeee097be5-c4aa-4584-bf6f-5c9dc2fc615c2021-01-14WarningsExact identifier
spl set id: ee097be5-c4aa-4584-bf6f-5c9dc2fc615c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.